Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,472 | -14,833 | -8,664 | -5,140 | -10,490 |
| Depreciation Amortization | 27 | 21 | 13 | 7 | 24 |
| Accounts receivable | -133 | -379 | -651 | N/A | N/A |
| Accounts payable and accrued liabilities | 332 | 110 | 61 | -71 | -269 |
| Other Working Capital | 14 | 2,379 | -24 | 437 | -385 |
| Other Operating Activity | 1,658 | 1,843 | 1,838 | 1,061 | 957 |
| Operating Cash Flow | $-14,573 | $-10,860 | $-7,426 | $-3,707 | $-10,163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -26 | -19 | -9 | -20 |
| Investing Cash Flow | $-35 | $-26 | $-19 | $-9 | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,314 | -2,460 | -1,623 | -804 | -1,812 |
| Common Stock Issued | 2,003 | 1,000 | N/A | N/A | 23,685 |
| Other Financing Activity | -115 | -2 | -214 | -41 | -2,271 |
| Financing Cash Flow | $-1,426 | $-1,461 | $-1,837 | $-845 | $19,603 |
| Beginning Cash Position | 21,162 | 21,162 | 21,162 | 21,162 | 11,742 |
| End Cash Position | 5,128 | 8,815 | 11,880 | 16,602 | 21,162 |
| Net Cash Flow | $-16,034 | $-12,347 | $-9,282 | $-4,560 | $9,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,573 | -10,860 | -7,426 | -3,707 | -10,163 |
| Capital Expenditure | -35 | -26 | -19 | -9 | -20 |
| Free Cash Flow | -14,608 | -10,886 | -7,445 | -3,716 | -10,183 |